Answers are grounded in this paper and cite their sources.
[99mTc]Tc-tilmanocept had a higher injection site clearance, but at the same time a lower uptake in the SLN, resulting in an SLN to injection site ratio, which was not significantly different from [99mTc]Tc-nanocolloid. The relatively low-radioactive uptake in SLNs of [99mTc]Tc-tilmanocept may limit intraoperative detection of SLNs, but can be overcome by a higher injection dose.
No takes yet. Share an insight, caveat, or question.
Toom et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: